-
-
-
I2304-100G
1-Indanone (C15-1284-234)
Price: $644.57List Price: $716.19Application 1-Indanone can be used to synthesize: 11 H -Indeno-[1,2- b ]-quinolin-10-ylamine, a potential acetylcholinesterase inhibitor for the treatment of Alzheimer′s disease. CoumBARAC (coumarin fused biarylazacyclooctynone) for -
I2304-10G
1-Indanone (C15-1284-235)
Price: $145.89List Price: $162.10Application 1-Indanone can be used to synthesize: 11 H -Indeno-[1,2- b ]-quinolin-10-ylamine, a potential acetylcholinesterase inhibitor for the treatment of Alzheimer′s disease. CoumBARAC (coumarin fused biarylazacyclooctynone) for -
I2304-25G
1-Indanone (C15-1284-236)
Price: $211.71List Price: $235.24Application 1-Indanone can be used to synthesize: 11 H -Indeno-[1,2- b ]-quinolin-10-ylamine, a potential acetylcholinesterase inhibitor for the treatment of Alzheimer′s disease. CoumBARAC (coumarin fused biarylazacyclooctynone) for -
83612
1-Undecyne, 97%, 25G
Price: $545.92List Price: $606.58CH<sub>3</sub>(CH<sub>2</sub>)<sub>8</sub>C&equivCH CAS#: 2243-98-3 F.W.: 152.28 -
180351-25G
2-Indanol
Price: $262.61List Price: $291.792-Indanol is stabilized by internal hydrogen bonding in its most stable form . The resonantly enhanced multiphoton ionization (REMPI) and zero kinetic energy (ZEKE) photoelectron spectroscopy of 2-indanol was studied . -
146692-10G
2-Indanone (C15-1253-080)
Price: $373.41List Price: $414.902-Indanone undergoes TiCl 4 -Mg mediated coupling with CHBr 3 to yield dibromomethyl carbinol . It reacts with 5,5-dimethyl-3-pyrazolidinone to yield 5,5-dimethyl-2-(1 H -indenyl-2)-3-pyrazolidinone . -
146692-50G
2-Indanone (C15-1253-081)
Price: $399.58List Price: $443.982-Indanone undergoes TiCl 4 -Mg mediated coupling with CHBr 3 to yield dibromomethyl carbinol . It reacts with 5,5-dimethyl-3-pyrazolidinone to yield 5,5-dimethyl-2-(1 H -indenyl-2)-3-pyrazolidinone . -
391743-25G
2-Methyl-1-indanone
Price: $1,218.17List Price: $1,353.522-Methyl-1-indanone, a α-benzocycloalkenone , is a derivative of 1-indanone. Its synthesis has been reported. -
-